AROI-ESTRO GYN Teaching Course

FIGO staging 2008

Stage I: confined to cervix > Ia1: minimal microscopic invasion > Ia2: invasion ≤ 5mm depth and ≤ 7mm horizontally > Ib1: greater than Ia, clinically visible, confined to the cervix, ≤ 4 cm size > Ib2: > 4 cm size 5-year survival: 89.1%



5-year survival : 75.7%

 Stage II: invades beyond cervix but not to side wall or lower third of vagina > IIa: tumour without parametrial invasion

• IIa1: ≤ 4 cm size • IIa2: > 4 cm size > IIb: tumour with parametrial invasion

 Stage III: tumour extends to pelvic sidewall and/or lower third of vagina

or causes hydronephrosis or non-functioning kidney > IIIa: lower third of vagina, no pelvic side wall extension > IIIb: involving pelvic side wall or causing hydronephrosis

 Stage IV: tumour invades mucosa of bladder or rectum and/or extends